相似文献
1
Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2017 Sep;15(9):1140-1163. doi: 10.6004/jnccn.2017.0146.
2
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2018 Oct;16(10):1216-1247. doi: 10.6004/jnccn.2018.0078.
3
NCCN Guidelines Insights: Survivorship, Version 1.2016.
J Natl Compr Canc Netw. 2016 Jun;14(6):715-24. doi: 10.6004/jnccn.2016.0073.
4
NCCN Guidelines® Insights: Survivorship, Version 1.2022.
J Natl Compr Canc Netw. 2022 Oct;20(10):1080-1090. doi: 10.6004/jnccn.2022.0052.
5
NCCN Guidelines Insights: Survivorship, Version 2.2020.
J Natl Compr Canc Netw. 2020 Aug;18(8):1016-1023. doi: 10.6004/jnccn.2020.0037.
6
NCCN Guidelines® Insights: Survivorship, Version 1.2023.
J Natl Compr Canc Netw. 2023 Aug;21(8):792-803. doi: 10.6004/jnccn.2023.0041.
7
Survivorship: introduction and definition. Clinical practice guidelines in oncology.
J Natl Compr Canc Netw. 2014 Jan;12(1):34-45. doi: 10.6004/jnccn.2014.0005.
8
NCCN Guidelines Insights: Survivorship, Version 2.2019.
J Natl Compr Canc Netw. 2019 Jul 1;17(7):784-794. doi: 10.6004/jnccn.2019.0034.
9
Sexual Function in Cancer Survivors: Updates to the NCCN Guidelines for Survivorship.
J Natl Compr Canc Netw. 2016 May;14(5 Suppl):685-9. doi: 10.6004/jnccn.2016.0193.
10
Survivorship, Version 1.2021.
J Natl Compr Canc Netw. 2021 Jun 30;19(6):676-685. doi: 10.6004/jnccn.2021.0028.
引用本文的文献
1
Molecular characterization and antibiotic susceptibility of methicillin-resistant in immunocompromised cancer patients.
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251352258. doi: 10.1177/03946320251352258. Epub 2025 Aug 25.
2
Perceptions about oncological physiotherapy among health and social care professionals and cancer care managers: a co-design approach for implementation strategies.
Support Care Cancer. 2025 Aug 18;33(9):793. doi: 10.1007/s00520-025-09785-z.
3
Investigating the impact of trial retractions on the healthcare evidence ecosystem (VITALITY Study I): retrospective cohort study.
BMJ. 2025 Apr 23;389:e082068. doi: 10.1136/bmj-2024-082068.
4
Clinical and biochemical amenorrhea in premenopausal patients with breast cancer treated with chemotherapy - a prospective cohort study.
BMC Cancer. 2025 Apr 22;25(1):753. doi: 10.1186/s12885-025-14159-z.
5
Breast cancer patients' experience of menopause care in the UK: thematic analysis of free-text comments.
Menopause. 2025 May 1;32(5):409-419. doi: 10.1097/GME.0000000000002505.
6
Patient experience of menopause care after breast cancer in the UK: a cross-sectional study.
Menopause. 2025 May 1;32(5):396-408. doi: 10.1097/GME.0000000000002504.
7
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.
Sci Rep. 2024 Oct 9;14(1):23556. doi: 10.1038/s41598-024-75293-5.
8
Sleep disturbances based on patient reported outcomes in patients with breast cancer.
Sleep Breath. 2024 Dec;28(6):2491-2500. doi: 10.1007/s11325-024-03150-w. Epub 2024 Sep 3.
9
Characterization of cancer survivors clustered by subjective and objective cognitive function scores.
Cancer Med. 2024 Jun;13(12):e7255. doi: 10.1002/cam4.7255.
10
Factorial Trial to Optimize an Internet-Delivered Intervention for Sexual Health After Breast Cancer: Protocol for the WF-2202 Sexual Health and Intimacy Enhancement (SHINE) Trial.
JMIR Res Protoc. 2024 Aug 19;13:e57781. doi: 10.2196/57781.
本文引用的文献
1
Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10μg estradiol on symptoms of vulvovaginal atrophy.
J Steroid Biochem Mol Biol. 2017 Nov;174:1-8. doi: 10.1016/j.jsbmb.2017.03.014. Epub 2017 Mar 18.
2
Efficacy of Internet-Based Cognitive Behavioral Therapy in Improving Sexual Functioning of Breast Cancer Survivors: Results of a Randomized Controlled Trial.
J Clin Oncol. 2017 Apr 20;35(12):1328-1340. doi: 10.1200/JCO.2016.69.6021. Epub 2017 Feb 27.
3
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.
Lancet Oncol. 2017 Feb;18(2):e75-e90. doi: 10.1016/S1470-2045(17)30026-8.
4
Long-term hormone therapy for perimenopausal and postmenopausal women.
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
5
Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
Mayo Clin Proc. 2017 Jan;92(1):114-128. doi: 10.1016/j.mayocp.2016.09.018. Epub 2016 Dec 1.
6
Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial.
Menopause. 2017 May;24(5):517-523. doi: 10.1097/GME.0000000000000779.
7
Patient-provider communication about sexual concerns in cancer: a systematic review.
J Cancer Surviv. 2017 Apr;11(2):175-188. doi: 10.1007/s11764-016-0577-9. Epub 2016 Nov 17.
8
Mind-body interventions for vasomotor symptoms in healthy menopausal women and breast cancer survivors. A systematic review.
J Psychosom Obstet Gynaecol. 2017 Sep;38(3):210-225. doi: 10.1080/0167482X.2016.1235147. Epub 2016 Nov 11.
9
Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol. 2017 Mar 1;3(3):313-319. doi: 10.1001/jamaoncol.2016.3904.
10
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
Gynecol Oncol. 2016 Dec;143(3):584-588. doi: 10.1016/j.ygyno.2016.10.006. Epub 2016 Oct 15.
Zotero 插件